Literature DB >> 25172181

Hyperphosphorylation of Tau at Ser396 occurs in the much earlier stage than appearance of learning and memory disorders in 5XFAD mice.

Takeshi Kanno1, Ayako Tsuchiya1, Tomoyuki Nishizaki2.   

Abstract

The present study investigated the relation of age-dependent spatial learning/memory impairment and Tau phosphorylation in 5XFAD mice, a model of Alzheimer's disease. In the water maze test, the acquisition and retention latencies for 5XFAD mice at 6 months, but not 2 months, of age was significantly longer than those for wild-type mice at the same months of age, without difference in the swim speed and visual acuity between two groups. The level of glycogen synthase kinase 3β (GSK-3β) phosphorylation at Ser9 in the hippocampus for the 5XFAD mice at >4 months of age was significantly lesser than that for wild-type mice at the same months of age, while a robust increase in the Tyr216 phosphorylation of GSK-3β was found both in wild-type and 5XFAD mice at 6 months of age, without no significant difference in the extent between two groups. There was no significant difference in the Tau phosphorylation at Ser202/Thr205 in the hippocampus between two groups, but Ser396 phosphorylation for 5XFAD mice was significantly higher than that for wild-type mice at ages ranging from 2 to 6 months. The results of the present study indicate that Tau hyperphosphorylation in the brain for 5XFAD mice precedes high activation of GSK-3β and occurs in the much earlier stage than appearance of learning and memory disorders.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5XFAD mouse; GSK-3β; Spatial learning and memory; Tau; Water maze test

Mesh:

Substances:

Year:  2014        PMID: 25172181     DOI: 10.1016/j.bbr.2014.08.034

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  20 in total

1.  Role of GSK3β/α-synuclein axis in methamphetamine-induced neurotoxicity in PC12 cells.

Authors:  Lizeng Li; Si Chen; Yue Wang; Xia Yue; Jingtao Xu; Weibing Xie; Pingming Qiu; Chao Liu; AiFeng Wang; Huijun Wang
Journal:  Toxicol Res (Camb)       Date:  2017-12-22       Impact factor: 3.524

2.  LINGO-1 antibody ameliorates myelin impairment and spatial memory deficits in the early stage of 5XFAD mice.

Authors:  Di Wu; Xiang Tang; Li-Hua Gu; Xiao-Li Li; Xin-Yang Qi; Feng Bai; Xiao-Chun Chen; Jian-Zhi Wang; Qing-Guo Ren; Zhi-Jun Zhang
Journal:  CNS Neurosci Ther       Date:  2018-02-09       Impact factor: 5.243

3.  Poloxamer-188 Exacerbates Brain Amyloidosis, Presynaptic Dystrophies, and Pathogenic Microglial Activation in 5XFAD Mice.

Authors:  Antonio Di Meco; Shahrnaz Kemal; Jelena Popovic; Sidhanth Chandra; Katherine Sadleir; Robert Vassar
Journal:  Curr Alzheimer Res       Date:  2022       Impact factor: 3.040

4.  Fuzhisan, a chinese herbal medicine, suppresses beta-secretase gene transcription via upregulation of SIRT1 expression in N2a-APP695 cells.

Authors:  Ran Gao; Ye Wang; Qingge Pan; Gaoya Huang; Nan Li; Jing Mou; Desheng Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer's disease.

Authors:  Leon M Tai; Deebika Balu; Evangelina Avila-Munoz; Laila Abdullah; Riya Thomas; Nicole Collins; Ana Carolina Valencia-Olvera; Mary Jo LaDu
Journal:  J Lipid Res       Date:  2017-04-07       Impact factor: 5.922

6.  Identification of key transcriptome biomarkers based on a vital gene module associated with pathological changes in Alzheimer's disease.

Authors:  Tong Zhang; Yang Shen; Yiqing Guo; Junyan Yao
Journal:  Aging (Albany NY)       Date:  2021-05-24       Impact factor: 5.682

7.  Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice.

Authors:  Christian Griñán-Ferré; Sara Sarroca; Aleksandra Ivanova; Dolors Puigoriol-Illamola; Fernando Aguado; Antoni Camins; Coral Sanfeliu; Mercè Pallàs
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

8.  Fructus mume extracts alleviate cognitive impairments in 5XFAD transgenic mice.

Authors:  Jung-Cheol Park; Jinhua Ma; Won Kyung Jeon; Jung-Soo Han
Journal:  BMC Complement Altern Med       Date:  2016-02-06       Impact factor: 3.659

9.  Spatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging.

Authors:  Xiang Tang; Di Wu; Li-Hua Gu; Bin-Bin Nie; Xin-Yang Qi; Yan-Juan Wang; Fang-Fang Wu; Xiao-Li Li; Feng Bai; Xiao-Chun Chen; Lin Xu; Qing-Guo Ren; Zhi-Jun Zhang
Journal:  Oncotarget       Date:  2016-09-06

10.  Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice.

Authors:  Yongjia Zhao; Xin Chen; Yichen Wu; Yanling Wang; Yifei Li; Charlie Xiang
Journal:  Front Mol Neurosci       Date:  2018-04-24       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.